Literature DB >> 23116937

In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk.

Louise M Stewart1, C D'Arcy J Holman, Patrick Aboagye-Sarfo, Judith C Finn, David B Preen, Roger Hart.   

Abstract

OBJECTIVES: To examine the risk of invasive epithelial ovarian cancer in a cohort of women seeking treatment for infertility.
METHODS: Using whole-population linked hospital and registry data, we conducted a cohort study of 21,646 women commencing hospital investigation and treatment for infertility in Western Australia in the years 1982-2002. We examined the effects of IVF treatment, endometriosis and parity on risk of ovarian cancer and explored potential confounding by tubal ligation, hysterectomy and unilateral oophorectomy/salpingo-oophorectomy (USO).
RESULTS: Parous women undergoing IVF had no observable increase in the rate of ovarian cancer (hazard ratio [HR] 1.01; 95% confidence interval [CI] 0.35-2.90); the HR in women who had IVF and remained nulliparous was 1.76 (95% CI 0.74-4.16). Women diagnosed with endometriosis who remained nulliparous had a three-fold increase in the rate of ovarian cancer (HR 3.11; 95% CI 1.13-8.57); the HR in parous women was 1.52 (95% CI 0.34-6.75). In separate analyses, women who had a USO without hysterectomy had a four-fold increase in the rate of ovarian cancer (HR 4.23; 95% CI 1.30-13.77). Hysterectomy with or without USO appeared protective.
CONCLUSIONS: There is no evidence of an increased risk of ovarian cancer following IVF in women who give birth. There is some uncertainty regarding the effect of IVF in women who remain nulliparous. Parous women diagnosed with endometriosis may have a slightly increased risk of ovarian cancer; nulliparous women have a marked increase in risk.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23116937     DOI: 10.1016/j.ygyno.2012.10.023

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  27 in total

Review 1.  Use of fertility drugs and risk of ovarian cancer.

Authors:  Brenda Diergaarde; Michelle L Kurta
Journal:  Curr Opin Obstet Gynecol       Date:  2014-06       Impact factor: 1.927

2.  Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis.

Authors:  Zhiyi Zhou; Fangfang Zeng; Jianhui Yuan; Jinling Tang; Graham A Colditz; Shelley S Tworoger; Britton Trabert; Xuefen Su
Journal:  Cancer Causes Control       Date:  2017-03-24       Impact factor: 2.506

3.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-06-18

4.  Cancer Risk in Women Treated with Fertility Drugs According to Parity Status-A Registry-based Cohort Study.

Authors:  Marte Myhre Reigstad; Ritsa Storeng; Tor Åge Myklebust; Nan Birgitte Oldereid; Anne Katerine Omland; Trude Eid Robsahm; Louise Annette Brinton; Siri Vangen; Kari Furu; Inger Kristin Larsen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-20       Impact factor: 4.254

Review 5.  Do women offered assisted reproduction technologies have a higher incidence of gynecologic cancer? A systematic review and meta-analysis.

Authors:  Juan Enrique Schwarze; Paulina Valdebenito; Carolina Ortega; Sonia Villa; Javier Crosby; Ricardo Pommer
Journal:  JBRA Assist Reprod       Date:  2017-06-01

6.  In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services.

Authors:  Louise A Brinton; Britton Trabert; Varda Shalev; Eitan Lunenfeld; Tal Sella; Gabriel Chodick
Journal:  Fertil Steril       Date:  2013-01-30       Impact factor: 7.329

Review 7.  Endometriosis-associated Malignancy.

Authors:  N Krawczyk; M Banys-Paluchowski; D Schmidt; U Ulrich; T Fehm
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-02       Impact factor: 2.915

8.  Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies.

Authors:  Megan S Rice; Susan E Hankinson; Shelley S Tworoger
Journal:  Fertil Steril       Date:  2014-05-10       Impact factor: 7.329

Review 9.  What are the risks of the assisted reproductive technologies (ART) and how can they be minimized?

Authors:  Robert W Rebar
Journal:  Reprod Med Biol       Date:  2013-06-11

Review 10.  Metastatic gynecologic malignancies: advances in treatment and management.

Authors:  John K Chan; Stephanie Chow; Subasish Bhowmik; Amandeep Mann; Daniel S Kapp; Robert L Coleman
Journal:  Clin Exp Metastasis       Date:  2018-06-21       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.